Park Ha Biological Technology Co Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $2.5M+6.0% YoYTTM through 31 Oct 2025
Net Income -$24.4M-5,191.3% YoYTTM through 31 Oct 2025
Free Cash Flow -$3KTTM through 31 Oct 2025
Margins
| Current | |
|---|---|
| Gross Margin | 94.4% |
| EBITDA Margin | -952.1% |
| Operating Margin | -956.5% |
| Net Margin | -965.0% |
Balance Sheet Health
Debt / Equity0.05x
Current Ratio2.92x
Net Debt-$3.6Mnet cash position
Cash & Equivalents$3.8M
Quality Metrics
Altman Z-Score-17.31
Piotroski F-Score4 / 9
FCF Margin-0.1%
Multi-Year Trend
RevenueFY2025: $2.5M
Diluted EPSFY2025: $-41.38
Dividend
No dividend
Capital Allocation
R&D Spend$238.2K
Capex Intensity3.5%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Product Sales | $716.1K | +77.0% | View detailsEngaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. |
| Franchise Service | $541.6K | -35.0% | View detailsEngaged in entering franchise agreements with its franchisees, granting permission to open and operate stores under the brand names Park Ha or Geni. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.